Management of Subclinical Hypothyroidism: A Focus on Proven Health Effects in the 2023 Korean Thyroid Association Guidelines.
Journal Information
Full Title: Endocrinol Metab (Seoul)
Abbreviation: Endocrinol Metab (Seoul)
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Endocrinology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported."
"This research was supported by a grant from the Patient Centered Clinical Research Coordinating Center funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HC19C0103040020). The funding source had no role in the collection of the data or in the decision to submit the manuscript for publication. The funding sources did not have a role in the design, data collection, analysis, interpretation of data, or writing of the manuscript of this study. We thank all members of the task force team (Yea Eun Kang, Kyeong Jin Kim, Bo Hyun Kim, Tae-Yong Kim, Chang Ho Ahn, Jee Hee Yoon, Jong Min Lee, Eui Dal Jung, Jae Hoon Chung, Yun Jae Chung, Won Bae Kim, Ka Hee Yi, Ho-Cheol Kang, and Do Joon Park) who participated in the work of the 2023 Korean Thyroid Association (KTA) Management Guidelines for Patients with Subclinical Hypothyroidism and we also thank Young Joo Park and Eun Kyung Lee, the director and secretary of the Practice Guideline Committee of KTA."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025